Entegrion's VCM Analyzer

Uncontrolled coagulopathy is a major cause of mortality in trauma, surgery, disease states and cardiac therapies. Routine point of care coagulation tests are limited in the information provided to assess and manage these, while laboratory diagnostic tests offer more clinical information at the cost of being more expensive and time delayed. With as many as 800 million PT/PTT coagulation tests requested worldwide in point of care testing, there is a clear need for high quality, easy-to-use, and rapid patient-side coagulation assessment. 

The VCM testing platform offers a cost effective, accurate, easy to use, and reliable global coagulation solution in just minutes. Entegrion’s VCM platform is changing hemostasis assessment, providing a more complete answer for diagnostics, monitoring, and critical pathways management at the bedside.